Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-26 4:04 pm Purchase | 2022-09-20 | 13D | Milestone Pharmaceuticals Inc. MIST | Novo Holdings A/S | 2,097,713 7.000% | 16,828 (+0.81%) | Filing History |
| 2022-09-19 9:14 pm Purchase | 2022-09-09 | 13G | Milestone Pharmaceuticals Inc. MIST | Venrock Healthcare Capital Partners III L.P. | 2,072,009 6.900% | 2,072,009 (New Position) | Filing History |
| 2022-02-14 4:54 pm Sale | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 2,238,861 7.500% | -238,333 (-9.62%) | Filing History |
| 2022-02-14 4:36 pm Sale | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Ikarian Capital LLC | 1,750,043 5.900% | -86,502 (-4.71%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RA CAPITAL MANAGEMENT L.P. | 2,246,503 7.500% | -81,211 (-3.49%) | Filing History |
| 2022-02-14 08:03 am Sale | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RTW INVESTMENTS LP | 4,315,102 14.400% | -99 (-0.00%) | Filing History |
| 2022-02-11 4:32 pm Purchase | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | ORBIMED CAPITAL LLC | 2,583,821 8.700% | 90,712 (+3.64%) | Filing History |
| 2021-02-16 4:57 pm Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 2,477,194 8.300% | 700,000 (+39.39%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RA CAPITAL MANAGEMENT L.P. | 2,327,714 7.800% | 2,327,714 (New Position) | Filing History |
| 2021-02-16 12:24 pm Sale | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | PRICE T ROWE ASSOCIATES INC | 374,957 1.200% | -911,550 (-70.85%) | Filing History |
| 2021-02-16 06:10 am Sale | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Forbion Capital Fund III Cooperatief U.A. | 0 0.000% | -1,303,902 (Position Closed) | Filing History |
| 2021-02-12 5:03 pm Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | ORBIMED CAPITAL LLC | 2,493,109 8.360% | 2,493,109 (New Position) | Filing History |
| 2021-02-12 09:28 am Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RTW INVESTMENTS LP | 4,315,201 14.460% | 356,937 (+9.02%) | Filing History |
| 2021-02-11 7:10 pm Sale | 2021-02-11 | 13G | Milestone Pharmaceuticals Inc. MIST | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 1,387,393 4.700% | -1,332,917 (-49.00%) | Filing History |
| 2021-01-20 6:33 pm Sale | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Domain Partners VIII L.P. | 860,724 2.900% | -1,012,381 (-54.05%) | Filing History |
| 2021-01-11 5:25 pm Purchase | 2020-08-03 | 13G | Milestone Pharmaceuticals Inc. MIST | Ikarian Capital LLC | 1,836,545 6.200% | 1,836,545 (New Position) | Filing History |
| 2020-08-03 4:31 pm Purchase | 2020-07-23 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 1,777,194 7.200% | 1,777,194 (New Position) | Filing History |
| 2020-04-03 4:05 pm Sale | 2020-03-25 | 13G | Milestone Pharmaceuticals Inc. MIST | Venrock Healthcare Capital Partners II L.P. | 0 0.000% | -2,215,089 (Position Closed) | Filing History |